Alpha Sigma Capital led the seed investment to help Quant Network expand its blockchain interoperability technology into new markets.
"We just recognized that Quant is doing what Ripple promised. Quant and SIA Europe successfully tested cross-blockchain interoperability between multiple Distributed Ledger Technology (DLT) protocols on SIA’s inter-bank network, SIAnet. SIA is the backbone for financial institutions, central banks, corporates, and the public sector to process their transactions. It was clear that Quant’s operating system provides the layer for blockchain interoperability in the financial services sector."
Cambridge Enterprise backed the primary fixed income technology provider in its latest funding round.
"Our mission is to help optimise financial services by leveraging collective scale and intelligence for the benefit of all. We do this by making asset sourcing and placement faster, cheaper, and better."
The Imperial College spin-out has secured seed backing led by IQ Capital to scale its team and customer base.
"We are delighted to receive this funding from our investor partners – it’s a fantastic indication of their faith in the commercial applications of our technology. This funding will give TOffeeAM the opportunity to continue our success at speeding up 3D printing across all industries by up to 20 times faster and to expand our team with expert engineers and other team members, and continue to scale the solution to serve our rapidly expanding customer base. We are at the beginning of an exciting journey, and this funding will help drive our growth and the wider use of this transformative technology across a variety of industries."
The Oxford startup raised the capital from Microsoft's venture fund and Mayfield following its success in the Female Founders Competition.
"We are so excited to name iLoF a winner of the Female Founders Competition and invest $1 million alongside Mayfield. iLoF’s technology promises to create effective treatments tailored for the individual, which will change healthcare trajectories for millions of people living with complex disorders. Their mission is humbling, and we are thrilled to support this company with our investment and as a board observer."
